Literature DB >> 3728070

Drug use and psychiatric symptoms in adolescence.

N J Lavik, S Onstad.   

Abstract

Drug use and psychiatric symptoms were independently assessed in a random sample of 177 adolescents from a junior high school population. Pupils who used cigarettes, alcohol, cannabis, solutions (sniffing), and tranquilizers, all had higher frequencies of psychiatric symptoms than non-users. The use of alcohol was shown the lowest connection with psychiatric symptoms, especially among the males. Smoking was more frequent among the females, and the connection with psychiatric symptoms was stronger than in the males. The importance of both a clinical and a public health approach to drug use in this age group is stressed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3728070     DOI: 10.1111/j.1600-0447.1986.tb02708.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  5 in total

1.  Factors associated with adolescents receiving drug treatment: findings from the National Household Survey on Drug Abuse.

Authors:  Ping Wu; Christina W Hoven; Cordelia J Fuller
Journal:  J Behav Health Serv Res       Date:  2003 Apr-Jun       Impact factor: 1.505

2.  Smoking and drinking habits in adolescence--links with psychiatric disturbance at the age of 8 years.

Authors:  H Ebeling; I Moilanen; S L Linna; T Tirkkonen; T Ebeling; J Piha; K Kumpulainen; E Räsänen; T Tamminen; F Almqvist
Journal:  Eur Child Adolesc Psychiatry       Date:  1999       Impact factor: 4.785

3.  Drug abuse in children and adolescents: an update.

Authors:  H Swadi
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

Review 4.  The magnitude of concurrent psychiatric disorders in hospitalized substance abusing adolescents.

Authors:  Y Kaminer
Journal:  Child Psychiatry Hum Dev       Date:  1991

5.  A longitudinal perspective on adolescent substance abuse.

Authors:  Harith Swadi
Journal:  Eur Child Adolesc Psychiatry       Date:  1992-07       Impact factor: 4.785

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.